VBIV(Delisted)
VBI VaccinesยทNASDAQ
--
--(--)
VBIV fundamentals
VBI Vaccines (VBIV) released its earnings on May 1, 2018: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
May 1, 2018
EPS
Revenue
Revenue & Expenses
VBIV has released its 2024 Q1 earnings report, with revenue of 1.21M, reflecting a YoY change of 150.31%, and net profit of -17.90M, showing a YoY change of 35.50%. The Sankey diagram below clearly presents VBIV's revenue sources and cost distribution.
Key Indicators
VBI Vaccines (VBIV) key financial stats and ratios, covering profitability, financial health, and leverage.
VBI Vaccines (VBIV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
VBI Vaccines (VBIV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
VBI Vaccines (VBIV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does VBI Vaccines (VBIV) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track VBI Vaccines (VBIV) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
